Outset Medical Shares Rise After FDA Clears Upgraded Tablo Dialysis System
Outset Medical Inc (NASDAQ:OM) saw its stock jump 9% in premarket trading Tuesday after the company announced that the U.S. Food and Drug Administration cleared its next-generation Tablo hemodialysis platform. The updated system is the first dialysis unit cleared to meet the FDA's most stringent cybersecurity guidance published in June 2025 and inc…